Log In
BCIQ
Print this Print this
 

Rythmol SR, propafenone

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionExtended-release propafenone HCl
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationArrhythmia
Indication DetailsTreat arrhythmia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today